JPMorgan Chase & Co’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
|
|||||
|
2025
Q1 | $32.9K | Sell |
|
|||||
|
2024
Q4 | $67.7K | Buy |
|
|||||
|
2024
Q3 | $62.3K | Sell |
|
|||||
|
2024
Q2 | $779K | Buy |
|
|||||
|
2024
Q1 | $251 | Sell |
|
|||||
|
2023
Q4 | $87.4K | Sell |
|
|||||
|
2023
Q3 | $15.7M | Sell |
|
|||||
|
2023
Q2 | $15.2M | Sell |
|
|||||
|
2023
Q1 | $6.49M | Buy |
|
|||||
|
2022
Q4 | $471K | Buy |
|